Mistake 3: using the wrong amount of water This one cascades through every subsequent dose
Despite the risks, there are specific scenarios where a licensed healthcare professional might consider a combined approach
A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)
TA664 for liraglutide 3.0 mg) recommend considering GLP-1 agonists for adults with a BMI of 35 kg/m or more (or 32.5 kg/m or more for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds), or a BMI of 30-34.9 kg/m with at least one weight-related comorbidity
Overall, though, user feedback on the GLP-1 Booster has been largely positive
Hu J, Zhang Q, Ren X, Sun Z, Quan Q (2015) Efficacy and safety of acetylcysteine in non-acetaminophen acute liver failure: a meta-analysis of prospective clinical trials